Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI to Fund Genomics Courses for Biomedical Community

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute plans to fund development of short courses that will spread information about genomics methods and techniques and will update researchers on many of the ethical, legal, and social implications (ELSI) of new genomics advances.

Under a new funding opportunity, NHGRI will provide up to $50,000 to support classes less than two weeks in length that will be hosted by academic institutions or research institutes.

The aim is to spread knowledge among the larger biomedical research community about genomics advances or ELSI issues that are emerging from genomic medicine and to cross-train researchers in these issues.

"Genomics has stimulated and continues to stimulate the development of powerful new techniques, methods, and analyses, and biomedical research would benefit from the rapid, widespread dissemination of these methods to the larger biomedical research community. Short (a few days to two-week) courses have been a very effective means of achieving dissemination," NHGRI said in its funding announcement.

These courses should be targeted to individuals at the doctoral level and beyond and should be led by established investigators or scholars who are actively working in the areas that the courses will cover.

NHGRI will provide up to three years of support to fund these genomics education efforts.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.